Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Standardized Treatment of Pulmonary Exacerbations II (STOP2)

NCT02781610 is registered in ClinicalTrials.gov with Chris Goss as lead sponsor.

NCT NCT02781610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02781610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Standardized Treatment of Pulmonary Exacerbations II (STOP2)
Lead sponsor
Chris Goss
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2016
Completion date
March 6, 2020
Enrollment
982 (actual)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary cystic fibrosis